Controversies in the Treatment of Idiopathic Membranous Nephropathy

Nature Reviews Nephrology - United Kingdom
doi 10.1038/nrneph.2009.101
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cancer Risk After Cyclophosphamide Treatment in Idiopathic Membranous Nephropathy

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2014English

Chapter 7: Idiopathic Membranous Nephropathy

Kidney International Supplements
Nephrology
2012English

Variation of Peripheral Th17/Treg Imbalance in Patients With Idiopathic Membranous Nephropathy After Cyclosporin a Treatment: A Prognostic Marker of Idiopathic Membranous Nephropathy

Biomedical Journal of Scientific & Technical Research
2018English

Comparison of Prognostic, Clinical, and Renal Histopathological Characteristics of Overlapping Idiopathic Membranous Nephropathy and IgA Nephropathy Versus Idiopathic Membranous Nephropathy

Scientific Reports
Multidisciplinary
2017English

Evaluating Tacrolimus Treatment in Idiopathic Membranous Nephropathy in a Cohort of 408 Patients

BMC Nephrology
Nephrology
2017English

Management of Idiopathic Membranous Nephropathy: Evidence-Based Recommendations

Kidney International
Nephrology
1999English

Factors Affecting the Long-Term Outcomes of Idiopathic Membranous Nephropathy

BMC Nephrology
Nephrology
2017English

Idiopathic Membranous Nephropathy and IgG4: An Interesting Relationship

Clinical Nephrology
MedicineNephrology
2013English

Risk HLA-DQA1 and PLA2R1 Alleles in Idiopathic Membranous Nephropathy

New England Journal of Medicine
Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy